300981.SZ
中红医疗
SZSE · Healthcare · C 制造业 · CN
CNY 14.44
−1.97%Year over year
Reported trailing growth
- Revenue
- -7.7%
- EBITDA
- —
- EBIT
- —
- EPS
- -87.1%
- Free cash flow
- —
- Operating cash flow
- -47.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +14.7%
- EBITDA
- -11.4%
- EBIT
- -91.0%
- Net income
- -29.0%
- EPS
- -30.0%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026